CM Life Sciences II Inc. currently conducts no substantial business operations. Its primary goal is to complete a strategic business combination, which could involve a merger, stock or asset acquisition, or reorganization, with one or more enterprises within the life sciences field. The company was founded in 2020 and has its headquarters in New York City.
Columbus Circle Capital Corp II Announces Elroy Air Was Awarded an Up to $46M Contract with U.S. Army
Elroy Air, the pending business combination target of Columbus Circle Capital Corp II, was awarded a $46.1 million firm-fixed-price contract by the U.S. Army for the development of its Chaparral VTOL aircraft.
The award includes an immediate obligation of $5.1 million in FY26 funds, with work scheduled for completion in 2029, bolstering the company's defense revenue pipeline ahead of the SPAC merger.
The transaction values Elroy Air at $800 million pre-money and targets a Q4 2026 close, supported by over $165 million in committed PIPE capital including participation from manufacturing partner Kratos Defense.